Lai Leo Chan

Title: **Lai Leo Chan: Innovator in Antibody Fragment Production**

Introduction

Lai Leo Chan is a notable inventor based in Hong Kong, China, recognized for his innovative approach to producing antibody fragments. With a significant contribution to the field of biotechnology, Chan's work holds the potential for advancements in medical diagnostics and therapeutics.

Latest Patents

Chan holds one patent titled "Method of producing antibody fragment." This method involves administering an immunizing mixture containing a target antigen to a cartilaginous fish multiple times. Following this, he collects a blood sample from the fish and extracts RNAs, which are subjected to reverse transcription to create complementary DNA (cDNA). Additionally, there is an option to amplify the cDNA to obtain a mixture of amplified cDNAs, which is then purified. The patent also details methods for producing antibody fragments from sharks, outlines the resulting antibody fragments, provides a kit comprising these fragments, and includes methods for detecting the presence and/or amount of target antigens in samples.

Career Highlights

Lai Leo Chan is currently associated with the City University of Hong Kong, where he leverages his expertise to further his research and development efforts. His innovative methods could pave the way for new therapeutic strategies, marking significant progress in the field of antibody technology.

Collaborations

In his professional journey, Chan collaborates with esteemed colleagues, including Jiahai Shi and Likun Wei. Together, they contribute to advancements in biotechnology, focusing on enhancing the efficacy of medical solutions through innovative research practices.

Conclusion

Lai Leo Chan stands out as an influential figure in the realm of antibody research, particularly for his groundbreaking methodology in producing antibody fragments. His work not only highlights the potential of using cartilaginous fish in biomedical applications but also opens new avenues for tackling various health-related challenges. As he continues his journey at the City University of Hong Kong, the impact of his innovations is likely to resonate within the scientific community and beyond.